317 related articles for article (PubMed ID: 27672034)
21. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
22. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor.
Guseva NV; Rokhlin OW; Bair TB; Glover RB; Cohen MB
Oncotarget; 2012 Feb; 3(2):183-94. PubMed ID: 22383394
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor dampens tissue factor expression via nuclear factor-κB and early growth response protein 1.
Hoesel B; Mussbacher M; Dikorman B; Salzmann M; Assinger A; Hell L; Thaler J; Basílio J; Moser B; Resch U; Paar H; Mackman N; Schmid JA
J Thromb Haemost; 2018 Apr; 16(4):749-758. PubMed ID: 29427323
[TBL] [Abstract][Full Text] [Related]
25. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.
Chen ST; Okada M; Nakato R; Izumi K; Bando M; Shirahige K
J Biol Chem; 2015 Aug; 290(35):21713-23. PubMed ID: 26175158
[TBL] [Abstract][Full Text] [Related]
26. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
27. Chromatin binding by the androgen receptor in prostate cancer.
Itkonen H; Mills IG
Mol Cell Endocrinol; 2012 Sep; 360(1-2):44-51. PubMed ID: 21989426
[TBL] [Abstract][Full Text] [Related]
28. Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells.
Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047218
[TBL] [Abstract][Full Text] [Related]
29. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
30. Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.
Guo J; Wei Z; Jia T; Wang L; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Wang K; Fu B; Chen SS
J Transl Med; 2023 Oct; 21(1):716. PubMed ID: 37828515
[TBL] [Abstract][Full Text] [Related]
31. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
32. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
[TBL] [Abstract][Full Text] [Related]
33. CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Augello MA; Liu D; Deonarine LD; Robinson BD; Huang D; Stelloo S; Blattner M; Doane AS; Wong EWP; Chen Y; Rubin MA; Beltran H; Elemento O; Bergman AM; Zwart W; Sboner A; Dephoure N; Barbieri CE
Cancer Cell; 2019 Apr; 35(4):603-617.e8. PubMed ID: 30930119
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
Urbanucci A; Sahu B; Seppälä J; Larjo A; Latonen LM; Waltering KK; Tammela TL; Vessella RL; Lähdesmäki H; Jänne OA; Visakorpi T
Oncogene; 2012 Apr; 31(17):2153-63. PubMed ID: 21909140
[TBL] [Abstract][Full Text] [Related]
35. TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.
Franco HL; Nagari A; Kraus WL
Mol Cell; 2015 Apr; 58(1):21-34. PubMed ID: 25752574
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB regulates androgen receptor expression and prostate cancer growth.
Zhang L; Altuwaijri S; Deng F; Chen L; Lal P; Bhanot UK; Korets R; Wenske S; Lilja HG; Chang C; Scher HI; Gerald WL
Am J Pathol; 2009 Aug; 175(2):489-99. PubMed ID: 19628766
[TBL] [Abstract][Full Text] [Related]
37. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?
Suh J; Rabson AB
J Cell Biochem; 2004 Jan; 91(1):100-17. PubMed ID: 14689584
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Wang Q; Li W; Zhang Y; Yuan X; Xu K; Yu J; Chen Z; Beroukhim R; Wang H; Lupien M; Wu T; Regan MM; Meyer CA; Carroll JS; Manrai AK; Jänne OA; Balk SP; Mehra R; Han B; Chinnaiyan AM; Rubin MA; True L; Fiorentino M; Fiore C; Loda M; Kantoff PW; Liu XS; Brown M
Cell; 2009 Jul; 138(2):245-56. PubMed ID: 19632176
[TBL] [Abstract][Full Text] [Related]
40. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]